Protheragen, a leading CRO in rare disease research, is proud to announce the launch of its groundbreaking disease model development platform. This platform is specifically designed to develop 2D cell culture, 3D organoid, and animal models to accelerate research and therapy development for rare diseases. This state-of-the-art platform combines cutting-edge technology, extensive biological...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek